Arotech Reports Profitable Fourth Quarter
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
Arotech Corp. (ARTX) Tops Q4 EPS by 7c; Offers Mixed FY16 Outlook
March 14, 2016 4:46 PM EDTArotech Corp. (NASDAQ: ARTX) reported Q4 EPS of $0.06, $0.07 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $27.4 million versus the consensus estimate of $27.7 million.
GUIDANCE:
Arotech Corp. sees FY2016 EPS of $0.18-$0.23, versus the consensus of... More
